Fu, Minyang
Hu, Yuan
Lan, Tianxia
Guan, Kun-Liang
Luo, Ting
Luo, Min http://orcid.org/0000-0002-6875-7945
Article History
Received: 24 June 2022
Revised: 9 September 2022
Accepted: 9 September 2022
First Online: 8 November 2022
Change Date: 4 January 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41392-023-01682-3
Competing interests
: K.L.G. is a co-founder of and has equity interest in Vivace Therapeutics. Other authors declare that they have no conflict of interest.